{
  "main_header": {
    "sid": 1241779,
    "name": "Knight Therapeutics, Inc.",
    "stock_name": "Knight Therapeutics, Inc.",
    "full_name": "Knight Therapeutics, Inc.",
    "name_url": "stocks-analysis/knight-therapeutics-inc",
    "exchange": 30,
    "exchangecode": "TSE",
    "country_id": 1,
    "currency": "CAD",
    "cmp": "6.05",
    "chg": 0.01,
    "chgp": "0.17%",
    "dir": 1,
    "prev_price": "6.04",
    "mcapval": "581.34",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P/TSX 60",
    "isin": "CA4990531069",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "40.95 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/knight-therapeutics-inc-1241779-30&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Knight Therapeutics Faces Financial Challenges Amid Valuation Score Revision",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/knight-therapeutics-downgraded-to-strong-sell-amid-profit-decline-and-rising-costs-3600292",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/KnightTherapeut_mojoScore_3600292.png",
        "date": "2025-10-07 20:13:46",
        "description": "Knight Therapeutics, Inc. has undergone a recent evaluation adjustment, highlighting a shift in its financial standing. Key metrics indicate challenges, including negative returns on capital and equity, alongside a decline in profit before tax. The company's valuation landscape remains complex amid these financial dynamics."
      }
    ],
    "total": 1,
    "sid": "1241779",
    "stock_news_url": "https://www.marketsmojo.com/news/knight-therapeutics-inc-1241779"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Knight Therapeutics Faces Financial Challenges Amid Valuation Score Revision

2025-10-07 20:13:46

Knight Therapeutics, Inc. has undergone a recent evaluation adjustment, highlighting a shift in its financial standing. Key metrics indicate challenges, including negative returns on capital and equity, alongside a decline in profit before tax. The company's valuation landscape remains complex amid these financial dynamics.

Read More

View All News